ALX ONCOLOGY HOLDINGS INC financial data

Symbol
ALXO on Nasdaq
Location
South San Francisco, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 07 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 464% % -5.4%
Debt-to-equity 44% % 38%
Return On Equity -139% % -49%
Return On Assets -97% % -37%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 54,218,001 shares 2.8%
Common Stock, Shares, Outstanding 53,577,566 shares 1.6%
Entity Public Float $251,200,000 USD 56%
Common Stock, Value, Issued $54,000 USD 1.9%
Weighted Average Number of Shares Outstanding, Basic 53,577,066 shares 1.7%
Weighted Average Number of Shares Outstanding, Diluted 53,577,066 shares 1.7%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $82,883,000 USD -38%
General and Administrative Expense $25,555,000 USD 1.2%
Operating Income (Loss) $111,613,000 USD 30%
Net Income (Loss) Attributable to Parent $108,010,000 USD 29%
Earnings Per Share, Basic -2 USD/shares 32%
Earnings Per Share, Diluted -2 USD/shares 32%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $23,442,000 USD 46%
Other Assets, Current $4,000 USD -99%
Assets, Current $66,516,000 USD -57%
Property, Plant and Equipment, Net $1,351,000 USD -57%
Operating Lease, Right-of-Use Asset $1,306,000 USD -69%
Other Assets, Noncurrent $9,018,000 USD -29%
Assets $82,723,000 USD -55%
Accounts Payable, Current $6,583,000 USD -17%
Employee-related Liabilities, Current $2,787,000 USD -40%
Liabilities, Current $27,722,000 USD -14%
Operating Lease, Liability, Noncurrent $2,718,000 USD -27%
Other Liabilities, Noncurrent $4,437,000 USD -34%
Liabilities $37,923,000 USD -22%
Accumulated Other Comprehensive Income (Loss), Net of Tax $43,000 USD -92%
Retained Earnings (Accumulated Deficit) $699,969,000 USD -18%
Stockholders' Equity Attributable to Parent $44,800,000 USD -67%
Liabilities and Equity $82,723,000 USD -55%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $24,663,000 USD 35%
Net Cash Provided by (Used in) Financing Activities $65,000 USD -98%
Net Cash Provided by (Used in) Investing Activities $27,645,000 USD 4.4%
Common Stock, Shares Authorized 1,000,000,000 shares 0%
Common Stock, Shares, Issued 53,577,566 shares 1.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $23,508,000 USD 45%
Deferred Tax Assets, Valuation Allowance $129,411,000 USD 34%
Operating Lease, Liability $3,708,000 USD -20%
Payments to Acquire Property, Plant, and Equipment $60,000 USD -59%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $108,530,000 USD 28%
Lessee, Operating Lease, Liability, to be Paid $4,497,000 USD -22%
Property, Plant and Equipment, Gross $3,179,000 USD -36%
Operating Lease, Liability, Current $990,000 USD 7.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $789,000 USD -32%
Deferred Tax Assets, Operating Loss Carryforwards $41,106,000 USD 55%
Unrecognized Tax Benefits $4,110,000 USD 32%
Operating Lease, Payments $322,000 USD 2.9%
Depreciation, Depletion and Amortization $211,000 USD -1.4%
Deferred Tax Assets, Net of Valuation Allowance $130,831,000 USD 34%
Share-based Payment Arrangement, Expense $15,731,000 USD -44%
Interest Expense $1,646,000 USD -4.1%